Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
+8.52%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$42.7B
AUM Growth
-$2.16B
(-4.8%)
Cap. Flow
-$4.85B
Cap. Flow
% of AUM
-11.36%
Top 10 Holdings %
Top 10 Hldgs %
17.46%
Holding
2,600
New
186
Increased
692
Reduced
1,373
Closed
340
Top Buys
| 1 |
Bank of America
BAC
|
+$404M |
| 2 |
Broadcom
AVGO
|
+$346M |
| 3 |
Merck
MRK
|
+$296M |
| 4 |
Wells Fargo
WFC
|
+$296M |
| 5 |
Cisco
CSCO
|
+$278M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$618M |
| 2 |
Amazon
AMZN
|
+$558M |
| 3 |
PayPal
PYPL
|
+$392M |
| 4 |
Netflix
NFLX
|
+$383M |
| 5 |
Advanced Micro Devices
AMD
|
+$351M |
Sector Composition
| 1 | Technology | 25.99% |
| 2 | Healthcare | 15.31% |
| 3 | Financials | 14.97% |
| 4 | Consumer Discretionary | 11.06% |
| 5 | Industrials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
JELD-WEN Holding
JELD
$541M
| $175K | ﹤0.01% |
11,100
-7,900
| -42% | -$125K |
|
|
KRON
2102
DELISTED
Kronos Bio
KRON
| $175K | ﹤0.01% |
175,400
-19,000
| -10% | -$19K |
|
2103
Columbia Financial
CLBK
$1.61B
| $174K | ﹤0.01% |
10,200
-3,000
| -23% | -$51.2K |
|
2104
Lyell Immunopharma
LYEL
$257M
| $173K | ﹤0.01% |
6,285
-880
| -12% | -$24.3K |
|
2105
The Honest Company
HNST
$432M
| $171K | ﹤0.01% |
47,900
-2,300
| -5% | -$8.21K |
|
2106
Inseego
INSG
$197M
| $168K | ﹤0.01% |
+10,300
| New | +$168K |
|
2107
Douglas Elliman
DOUG
$241M
| $165K | ﹤0.01% |
90,215
-16,200
| -15% | -$29.6K |
|
2108
MBIA
MBI
$381M
| $163K | ﹤0.01% |
+45,650
| New | +$163K |
|
2109
BioAtla
BCAB
$39.8M
| $162K | ﹤0.01% |
92,046
-61,254
| -40% | -$108K |
|
2110
Asure Software
ASUR
$216M
| $161K | ﹤0.01% |
17,800
-6,775
| -28% | -$61.3K |
|
|
MCHB
2111
Mechanics Bancorp Class A Common Stock
MCHB
$2.87B
| $161K | ﹤0.01% |
10,193
-11,400
| -53% | -$180K |
|
2112
Bioventus
BVS
$471M
| $161K | ﹤0.01% |
13,432
-78,100
| -85% | -$933K |
|
2113
Tilray
TLRY
$1.21B
| $160K | ﹤0.01% |
90,700
-12,600
| -12% | -$22.2K |
|
2114
ProQR Therapeutics
PRQR
$240M
| $159K | ﹤0.01% |
87,500
-44,000
| -33% | -$80.1K |
|
2115
Compass Therapeutics
CMPX
$594M
| $159K | ﹤0.01% |
86,400
-27,400
| -24% | -$50.4K |
|
2116
Permian Resources
PR
$9.86B
| $157K | ﹤0.01% |
11,567
-509,430
| -98% | -$6.93M |
|
2117
Ring Energy
REI
$207M
| $156K | ﹤0.01% |
97,700
+66,000
| +208% | +$106K |
|
2118
Enhabit
EHAB
$388M
| $156K | ﹤0.01% |
19,700
+3,200
| +19% | +$25.3K |
|
2119
Cambium Networks
CMBM
$19.5M
| $153K | ﹤0.01% |
83,600
+46,000
| +122% | +$84.2K |
|
2120
Reservoir Media
RSVR
$511M
| $152K | ﹤0.01% |
18,800
-26,200
| -58% | -$212K |
|
2121
Athira Pharma
ATHA
$15M
| $151K | ﹤0.01% |
337,600
-23,300
| -6% | -$10.4K |
|
2122
Hafnia
HAFN
$3.06B
| $149K | ﹤0.01% |
+20,800
| New | +$149K |
|
2123
Vaalco Energy
EGY
$410M
| $148K | ﹤0.01% |
25,838
-700
| -3% | -$4.02K |
|
2124
Tenaya Therapeutics
TNYA
$215M
| $147K | ﹤0.01% |
76,400
-3,600
| -5% | -$6.95K |
|
2125
Personalis
PSNL
$489M
| $147K | ﹤0.01% |
27,300
-61,100
| -69% | -$329K |
|